In the News

484 News Items found
Colorful representation of DNA sequence
Feature
3 Cancer Genes You've Never Heard Of
While BRCA genes garner most of the public's attention, they're not the only cancer-predisposition genes doctors test for.
Cell Therapy and Cell Engineering Facility
Snapshot
MSK physician-scientist Prasad Adusumilli is focused on developing more-effective immunotherapy approaches for treating tumors in the chest.
Pictured: X-ray Image
In the Lab
Scientists have identified genes and biological mechanisms that one day could be targeted with drugs to stop kidney cancer from spreading to the bone, brain, or other organs.
MSK colon cancer patient Derrick Edwin wearing triathlon medals stands with his wife AnnaMarie
Learn more about how MSK is helping a new generation of patients — including triathlete Derrick Edwin — to navigate work and careers while undergoing treatment for cancer.
AACR 2019 Annual Meeting
In the News
Read up on the latest developments in several important areas of cancer research emerging from the 2019 American Association for Cancer Research annual meeting.
A researcher working in an MSK lab
New MSK research uncovers unique genetic signatures in cancer patients of non-European ancestry; identifies social adversity as a potential risk factor for higher rates of triple-negative breast cancer among Black women; shows a web-based system could help head-and-neck cancer survivors report their concerns; and finds adding immunotherapy can boost the effectiveness for hard-to-treat follicular lymphomas.
MSK epidemiologist Mengmeng “Margaret” Du.
Learn how polycystic ovary syndrome (PCOS) may be linked to increased risk of pancreatic cancer.
MSK physicians and researchers discussed the latest trends in breast cancer research at the annual meeting held in San Antonio.
Image of a mobile phone with a strand of DNA
In the Clinic
A new project called the BRCA Exchange is sharing data about BRCA mutations and what they actually mean for cancer risk.
The latest results come from a team of MSK physicians and scientists (from left to right): Bob Li, Hai-Yan Tu, Mackenzie Myers, Flavia Michelini, Emiliano Cocco, Sandra Misale, and Maurizio Scaltriti
In the Clinic
Results from a clinical trial and animal studies provide support for targeting the HER2 protein in multiple cancer types.